Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis

Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis

Background: The global death toll from coronavirus disease 2019 (COVID-19) has exceeded 2 million, and treatments to decrease mortality are needed urgently. Objectives: To examine the probabilities of a clinically meaningful reduction in mortality for remdesivir and systemic corticosteroids. Design,...

Full description

Bibliographic Details
Main Authors: Todd C. Lee, Emily G. McDonald, Guillaume Butler-Laporte, Luke B. Harrison, Matthew P. Cheng, James M. Brophy
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:International Journal of Infectious Diseases
Subjects:
Remdesivir
Corticosteroids
Dexamethasone
COVID-19
Mortality
Bayesian meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221000771

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221000771

Similar Items